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Diabetic ketoacidosis (DKA) is one of the most serious 
acute complications of diabetes mellitus and is cha-
racterized by uncontrolled hyperglycemia, metabolic 
acidosis and ketosis. The reported incidence of dia-
betes mellitus in pregnancy ranges from 6 to 7% with 
90% occurring among women affected by gestatio-
nal diabetes mellitus (GDM) (1). The overall incidence 
of DKA occurrence during pregnancy is difficult to 
ascertain but some articles have reported an incidence 
between 1 and 3% (2, 3). Although it is a rare con-
dition, DKA in pregnancy is an urgent complication 
which can compromise both fetus and mother.
DKA is the result of an absolute or relative deficiency 
of insulin which causes a state of starvation of cells 
accompanied by an increased secretion of the counter-
regulatory hormones (cortisol, glucagon, epinephrine). 
The metabolic characteristics of DKA can trigger 
a chain of events that will self-perpetuate in a vicious 
cycle. Hyperglycemia gives rise to an osmotic gradient 
resulting in an excessive diuresis, which leads to severe 
dehydration and hypervolemia. This further aggravates 
the hyperglycemia and acidosis due to the activation 
of other stress hormones (growth hormone and corti-
sol), and osmotic diuresis causes low sodium levels (4).
Pregnant women with GDM are at greater risk for 
DKA than non-pregnant diabetic women (5). Factors 
that predispose the pregnant patient to DKA include 
accelerated starvation (especially in the second and 
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third trimesters), dehydration, decreased caloric intake 
(e.g., nausea or hyperemesis gravidarum), decreased 
buffering capacity (compensated respiratory alkalosis 
of pregnancy), stress, and increased production of 
insulin antagonists (human placental lactogen, pro-
lactin, and cortisol) (6). 
Euglycemic ketoacidosis is defined as severe ketoaci-
dosis in the absence of pronounced hyperglycemia. 
Euglycemic ketoacidosis has been reported in women 
with both pre-gestational diabetes mellitus (type 1 and 
type 2), and GDM. Guo et al. (7) demonstrated that 
DKA in pregnancy tends to occur at lower blood glu-
cose levels than DKA in nonpregnant diabetic women 
and sometimes as euglycemic ketoacidosis. They hypo-
thesized that low blood glucose levels are associated 
with an increase in glucose uptake by the fetoplacen-
tal unit as well as a decrease in glycogenolysis and 
hepatic glucose production. In addition, pregnancy 
predisposes the mother to accelerated starvation cha-
racterized by the switch from use of hepatic glycogen 
to lipolysis during fasting and associated with deve-
lopment of hypoglycemia, raised plasma levels of free 
fatty acids and increased plasma and urinary ketones 
(8). 
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A 27-year-old G2/P1 was admitted to our delivery 
room at 32 3/ 7 weeks with preterm labor. Type-1 dia-
betes mellitus had been diagnosed three years ago. 
Blood glucose levels were subsequently well controlled 
with insulin therapy. She had a history of vomiting for 
two days, as did her husband and other family mem-
bers. Tocolysis with hexoprenaline had already been 
initiated at the referring hospital. On admission, she 
was unwell with nausea, vomiting, frontal headache 
and painful contractions. She was tachycardic but 
normotensive. 
Urine dipstick revealed proteinuria and ketonuria. 
Blood glucose concentration was 7.5 mmol / l. There 
were no signs of preeclampsia other than headache. 
Transabdominal ultrasound revealed a normal amount 
of amniotic fluid, female sex, an estimated birth weight 
of 2600 g and cardiomegaly. Atosiban was added to 
hexoprenaline due to increasing contractions, and 
a first dose of dexamethasone was administered for 
fetal lung maturation. 
When the patient developed neurological symptoms, 
she received a magnesium sulfate infusion, although 
no additional signs of preeclampsia had developed in 
the meantime. Antibiotic therapy was initiated to treat 
group B streptoccocus detected in a vaginal swab. 
Hexoprenaline was stopped when the patient became 
increasingly tachycardic. Fetal heart rate (monitored 
via CTG) decreased and was temporarily not detec-
6Postmortem chest X-ray: bilateral chest drains and 
low lying umbilical venous catheter, no evidence of 
any air leaks.
Fig. 1
7table, so that ultrasound was used repeatedly. Finally, 
urgent Cesarean section was performed six hours after 
admission because of persistent fetal bradycardia. 
Apgar scores were 0, 0 and 0 at 1, 5 and 10 minutes, 
respectively. Cardiopulmonary resuscitation was initi-
ated immediately after birth and was performed per 
protocol, including immediate oral intubation and 
repeated administration of intravenous adrenaline. 
Fluid boli with normal saline 0.9% were given twice 
(25 ml each) and 60 ml of packed red cells were trans-
fused. No signs of air leaks were detected clinically 
or by transillumination; nevertheless, bilateral chest 
drains were placed (Fig.  1). Repeated echocardio-
graphy showed absent myocardial contractions, and, 
at 50 minutes of life, it was decided to discontinue 
resu scitation. 
During resuscitation, the following possible causes for 
cardiac arrest were excluded: hypovolemia, hypother-
mia, cardiac tamponade, tension pneumothorax, insuf-
ficient ventilation. Repeated blood gas analyses (drawn 
from the umbilical vein at birth and at 15  minutes of 
life) revealed severe hyperglycemic metabolic acido-
sis and raised potassium concentrations (Table  1). 
Just before resuscitation efforts were stopped, we 
were informed that the mother’s blood gas analysis 
also revealed severe hyperglycemia (blood glucose 
concentration 28  mmol/ l) and metabolic aci dosis (pH 
6.90) with a potassium level of 6.9 mmol/ l (Table 1). 
Blood 
gas 
analyses
pH
pCO2  
(kPA)
BE 
(mmol/l)
Potas-
sium 
(mmol/l)
Glucose 
(mmol/l)
Mother 6.95 3.3 -26 6.3 28
Infant – I 
Infant – II
6.78 
< 6.30
7.6 
18.2
-30 
?
7.1 
10.4
21.8 
23.4
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Table 1. Laboratory results
Suspected cause of death was severe prolonged 
metabolic acidosis, aggravated by fetal bradycardia. 
We cannot exclude additional factors, such as cardio-
myopathy or congenital heart disease due to diabetic 
fetopathy (birth weight 2710  g, > 97th percentile). 
The parents did not consent to autopsy.
Retrospectively, it was found that the patient had not 
injected her insulin for 58 hours due to her suspected 
gastroenteritis. On admission to our hospital, no blood 
gas analysis was performed until after birth and no 
insulin was given, as the patient and her husband, 
who also suffers from type 1 diabetes, claimed to be 
knowledgeable and competent to adjust their insulin 
requirements.
I: at birth, II: at 15 minutes of life
9In summary, this case report illustrates the significant 
impact of type 1 diabetes on fetal/neonatal outcome. 
For the prevention of cases like this, management for 
women with diabetes should be improved during preg-
nancy and on admission to the delivery room. Pregnant 
women and health care professionals involved in their 
care should be able to recognize signs and symptoms 
of diabetic ketoacidosis; in addition, appropriate labo-
ratory investigations (including blood glucose and 
electrolyte concentrations as well as a blood gas ana-
lysis) should be performed in every woman with type-1 
diabetes or insulin-dependent GDM on admission to 
the delivery room, especially when they present with 
preterm contractions and/or signs of diabetic ketoaci-
dosis (vomiting, headache, etc.).
It is important to keep in mind that there can be eugly-
cemia, especially in cases of starvation ketoacidosis 
due to nausea and/or vomiting and decreasing caloric 
intake without adequate insulin intake. Both are fre-
quent situations in obstetric patients.
DKA should be ruled out as a differential diagnosis of 
preeclampsia, in particular prior to using steroids for 
fetal lung maturation or for chronic medical disorders 
because of the effects of steroids on serum glucose. 
Steroids can themselves lead to DKA (9). Of note, the 
effects of steroids will be more pronounced when used 
in association with beta sympathomimetic agents to 
treat uterine contractions or preterm labor.
DISCUSSION
1. Dalfrà MG, Burlina S, Sartore G, Lapolla A. Ketoacido-
sis in diabetic pregnancy. J Matern Fetal Neonatal Med 
2016;29:2889 – 2895 (Abstract)
2. Parker JA, Conway DL. Diabetes ketoacidosis in pregnancy. 
Obstet Gynecol Clin North Am 2007;34:533 – 543 (Abstract)
3. Ramin KD. Diabetic ketoacidosis in pregnancy. Obstet Gynecol 
Clin North Am 1999;26:481 – 488 (Abstract)
4. Foster DW, McGarry JD. The metabolic derangements and 
treatment of diabetic ketoacidosis. N Eng J Med 1983; 
309:159–169 (no abstract available)
5. Hollingsworth DR. Medical and obstetric complications of dia-
betic pregnancies: IDDM, NIDDM, and GDM. Bron DL, Mitchell 
C (Eds.), Pregnancy, Diabetes and Birth: A Management Guide 
(2nd edition), Williams & Wilkins, Baltimore (1992) (no abstract 
available)
6. Chauhan SP, Perry KG. Management of diabetic ketoacido-
sis in the obstetric patient. Obstet Gynecol Clin North Am 
1995;22:143 – 155 (Abstract)
7. Guo RX, Yang LZ, Li LX, Zhao XP. Diabetic ketoacidosis in 
pregnancy tends to occur at lower blood glucose levels: case-
control study and a case report of euglycemic diabetic ketoa-
cidosis in pregnancy. J Obstet Gynaecol Res 2008;34:324 – 330 
(Abstract)
8. Frise CJ, Mackillop L, Joash K, Williamson C. Starvation 
ketoacidosis in pregnancy, Eur J Obstet Gynecol Reprod Biol 
2013;167:1 – 7 (Abstract)
9. Bedalow A, Balasubramnyam A. Glucocorticoid-induced 
keto acidosis in gestational diabetes: sequelae of the acute 
treatment of preterm labor. Diabetes Care 1997;20:922 – 924 
(Abstract)
REFERENCES
10

SUPPORTED BY
CONTACT
  
Swiss Society of Neonatology
www.neonet.ch
webmaster@neonet.ch
co
n
ce
p
t 
&
 d
es
ig
n
 b
y 
m
es
ch
.c
h
